To Evaluate the Effectiveness(Immunogenicity) and Safety of 'GC1107' Administered Intramuscularly in Healthy Children

NCT01402713 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

311

Enrollment

INDUSTRY

Sponsor class

Conditions

Bacterial Infections

Interventions

BIOLOGICAL: GC1107
BIOLOGICAL: TD_PUR INJ / SK Td vaccine

Sponsor

Green Cross Corporation